IGKV1D-17

Across TCGA pan-cancer cohorts, IGKV1D-17 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of IGKV1D-17’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where IGKV1D-17 RNA is repressed in tumor relative to normal tissue. In most cancer types IGKV1D-17 is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.

COAD, LUAD, and READ are the cancer types where IGKV1D-17 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IGKV1D-17 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	III,IV	−2.152	<.001	8	view →
LUAD	All	All	+1.340	<.001	6	view →
READ	All	All	−2.255	.003	4	view →
BRCA	Female	All	−0.451	.011	4	view →
STAD	Male	IV	−4.580	.005	3	view →
KIRC	Male	All	+0.616	.002	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

IGKV1D-17–COAD

Open the COAD breakdown →